Valproic acid ameliorates coxsackievirus-B3-induced viral myocarditis by modulating Th17/Treg imbalance

BACKGROUND: Viral myocarditis, which is often caused by coxsackievirus B3 (CVB3), is a serious clinical disorder characterized by excessive myocardial inflammation. Valproic acid (VPA) is described as a histone deacetylase inhibitor that has anti-inflammatory effects in several inflammatory diseases...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Haibin, Guo, Xiaoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5057454/
https://www.ncbi.nlm.nih.gov/pubmed/27724948
http://dx.doi.org/10.1186/s12985-016-0626-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5057454/
https://www.ncbi.nlm.nih.gov/pubmed/27724948
http://dx.doi.org/10.1186/s12985-016-0626-z

Ejemplares similares